Cochrane Abstracts
Cisplatin versus carboplatin in combination with third‐generation drugs for advanced non‐small cell lung cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Cisplatin Versus Carboplatin in Combination With Third‐generation Drugs for Advanced Non‐small Cell Lung Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436771/1/Cisplatin_versus_carboplatin_in_combination_with_third‐generation_drugs_for_advanced_non‐small_cell_lung_cancer.
Cisplatin versus carboplatin in combination with third‐generation drugs for advanced non‐small cell lung cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436771/1/Cisplatin_versus_carboplatin_in_combination_with_third‐generation_drugs_for_advanced_non‐small_cell_lung_cancer. Accessed December 7, 2024.
Cisplatin versus carboplatin in combination with third‐generation drugs for advanced non‐small cell lung cancer. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436771/1/Cisplatin_versus_carboplatin_in_combination_with_third‐generation_drugs_for_advanced_non‐small_cell_lung_cancer
Cisplatin Versus Carboplatin in Combination With Third‐generation Drugs for Advanced Non‐small Cell Lung Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436771/1/Cisplatin_versus_carboplatin_in_combination_with_third‐generation_drugs_for_advanced_non‐small_cell_lung_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cisplatin versus carboplatin in combination with third‐generation drugs for advanced non‐small cell lung cancer
ID - 436771
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436771/1/Cisplatin_versus_carboplatin_in_combination_with_third‐generation_drugs_for_advanced_non‐small_cell_lung_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
